Merck To Pay $280 Million Dey Settlement

German drug maker Merck KGaA is responsible for paying a $280
million settlement Dey Pharma LP reached with the U.S. government,
Mylan Inc. says.

Mylan, the New Jersey pharmaceutical giant that acquired Dey in
2007, said in a release following Monday’s announcement of
the settlement of the Medicare and Medicaid reimbursement lawsuit
that Merck also is on the hook for all costs and expenses related
to similar pending and future suits involving its subsidiary.

The U.S. Justice Department’s lawsuit began before Mylan
acquired Dey.

Mylan said the settlement agreement is not an admission,
finding, or evidence of fault, liability or wrongdoing by Dey.